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Introduction: Vitamin D plays a key role in immune function. Deficiency may aggravate the incidence and
outcome of infectious complications in critically ill patients. We aimed to evaluate the prevalence of vitamin D
deficiency and the correlation between serum 25-hydroxyvitamin D (25(OH) D) and hospital mortality, sepsis
mortality and blood culture positivity.
Methods: In a single-center retrospective observational study at a tertiary care center in Graz, Austria, 655 surgical
and nonsurgical critically ill patients with available 25(OH) D levels hospitalized between September 2008 and
May 2010 were included. Cox regression analysis adjusted for age, gender, severity of illness, renal function and
inflammatory status was performed. Vitamin D levels were categorized by month-specific tertiles (high, intermediate,
low) to reflect seasonal variation of serum 25(OH) D levels.
Results: Overall, the majority of patients were vitamin D deficient (<20 ng/ml; 60.2%) or insufficient (≥20 and
<30 ng/dl; 26.3%), with normal 25(OH) D levels (>30 ng/ml) present in only 13.6%. The prevalence of vitamin D
deficiency and mean 25(OH) D levels was significantly different in winter compared to summer months (P <0.001).
Hospital mortality was 20.6% (135 of 655 patients). Adjusted hospital mortality was significantly higher in patients in
the low (hazard ratio (HR) 2.05, 95% confidence interval (CI) 1.31 to 3.22) and intermediate (HR 1.92, 95% CI 1.21 to
3.06) compared to the high tertile. Sepsis was identified as cause of death in 20 of 135 deceased patients (14.8%).
There was no significant association between 25(OH) D and C-reactive protein (CRP), leukocyte count or procalcitonin
levels. In a subgroup analysis (n = 244), blood culture positivity rates did not differ between tertiles (23.1% versus 28.2%
versus 17.1%, P = 0.361).
Conclusions: Low 25(OH) D status is significantly associated with mortality in the critically ill. Intervention studies are
needed to investigate the effect of vitamin D substitution on mortality and sepsis rates in this population.Introduction
In critical illness, sepsis is one of the leading causes of
death [1,2]. Despite the substantial improvement of clin-
ical outcomes since the introduction of early goal-directed
therapy [3], successful treatment remains a great challenge
depending mainly on rapid elimination of the responsible
microorganism in addition to supportive treatment
[1,4]. Nosocomial infections such as ventilator-associated* Correspondence: karin.amrein@medunigraz.at
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or catheter-associated urinary tract infection are common
in critical illness [5] and associated with excessive costs
and mortality [6].
The majority of critically ill patients are vitamin D
deficient [7-11]. Vitamin D status is a surrogate marker
of mobility and outdoor activities because the majority
of body stores are derived from solar UVB and only
negligible amounts may come from few, especially forti-
fied, dietary sources [12]. In higher (and lower) latitudes,
endogenous vitamin D synthesis is severely restricted
during the winter months because a more oblique angle
means less UVB reaches the earth [12]. Protective clothing,
air pollution and sunscreen also impair optimal cutaneousLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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vitamin D deficiency found worldwide, even in otherwise
healthy subjects [13].
Besides rickets and osteomalacia, the well-known
musculoskeletal manifestations of profound vitamin D
deficiency, there is now extensive literature on adverse
health outcomes in patients with vitamin D deficiency
including increased all-cause and cardiovascular mortal-
ity, cardiovascular events and impaired immune function
[12,14]. In adult and pediatric critically ill patients, low
vitamin D levels have been linked to poor outcomes
including higher mortality and extended length of stay
[15-20]. The largest observational study published to
date (n = 2,399) also reported a higher rate of blood
culture positivity in a subgroup with available blood cul-
ture results (n = 1,160) [17]. In a small (n = 81), but highly
relevant study, patients hospitalized for suspected infec-
tion with a baseline 25-hydroxyvitamin D (25(OH) D)
level <30 ng/ml had more severe sepsis and all patients
who died had a 25(OH) D level <30 ng/ml [21].
Most cell types, including many immune cells such as
macrophages, B and T cells, have a nuclear vitamin D
receptor (VDR), respond to the active metabolite 1,25-
dihydroxyvitamin D (1,25(OH)2D) and possess the en-
zyme 1α-hydroxylase, which is required to activate native
vitamin D to its major metabolite 1,25(OH)2D, respon-
sible for autocrine or paracrine function [22,23]. Vitamin
D seems to be essential in both the innate and the adap-
tive immune system for optimal function of antimicrobial
activity [24,25]. Thus, there is a strong biological rationale
that vitamin D is not only a surrogate marker of disease
severity but also a contributing factor to increased sepsis
incidence and severity [11,26]. We therefore analyzed
mortality and available clinical data on infectious diseases
in a large, retrospective data set of mixed critically ill
patients to allow for hypothesis generation and sample
size calculation for a planned randomized controlled trial
(RCT) at the same study site. We postulated that low
25(OH) D levels are associated with adverse outcomes
including blood culture positivity, all-cause and sepsis
mortality in an ICU setting.
Materials and methods
This was a retrospective observational study. The ethics
committee at the Medical University of Graz approved
the study before data retrieval and waived the require-
ment for informed consent because the investigators
devised procedures to protect the confidentiality of the
information to be collected. The primary endpoint was
the prevalence of vitamin D deficiency and insufficiency.
Secondary endpoints included the association of ICU
mortality and hospital mortality with 25(OH) D status,
adjusted for covariates like baseline Simplified Acute
Physiology Score II (SAPS II), age, gender, glomerularfiltration rate (GFR) and C-reactive protein (CRP). A sub-
group analysis was performed in patients with available
blood culture results during hospital stay. 25(OH) D was
measured from fresh blood samples on workdays with en-
zyme immunoassay (Immunodiagnostic Systems, Boldon,
UK) until June 2009 and with the IDS-iSYS, an assay
based on chemiluminescence technology (Immunodiag-
nostic Systems), thereafter (R2 0.93 at our laboratory). The
coefficient of variation for control material is 13% at
12 ng/ml, 10% at 31 ng/ml, and 9% at 64 ng/ml [26],
respectively. Samples were taken in the early morning
along with other routine laboratory tests. In the majority
of patients, 25(OH) D was analysed within 48 hours fol-
lowing ICU admission.
Study sites
The study was conducted at the University Medical Center
of Graz, Austria, a 1,559-bed tertiary care facility providing
medical care for the province of Styria and its capital city
Graz, Austria (47° degrees latitude). Patients admitted to
one of the intensive care units treating adult patients
between September 2008 and May 2010 were included in
this study. The ICUs include a medical, neurological,
cardiothoracic surgery and several mixed surgery units
with eight to fifteen beds.
Data retrieval
Adult patients were identified from the hospital’s routine
data management system by the Institute of Informatics,
Statistics and Documentation. Routine data gathered
during hospital stay, including cause of death (during
hospital stay) was extracted from the hospital’s medical
documentation system. Sepsis-associated mortality was
categorized by two physicians independently based upon
detailed review of nonsurvivors’ hospital charts using the
2001 international sepsis definitions conference’s publi-
cation [27].
Study population
A total of 655 unique patient data sets with at least one
available 25(OH) D level measured during ICU stay were
retrieved. In case of multiple results (or ICU stays) only
the first measurement (or ICU stay) was taken into ac-
count for analysis. The investigation time span had to be
limited after May 2010 because we started an intervention
study at the same ICUs [28].
Statistical analysis
Data were analyzed using SPSS Version 20.0 (IBM Corp.,
Armonk, NY, USA) and are expressed as mean ± standard
deviation or median (interquartile range) as appropriate.
Between-group comparisons were carried out using chi-
square test or Kruskal-Wallis test as appropriate. For
survival analyses, Cox regression analyses adjusted for
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was used. There was no ethnicity difference in the popula-
tion studied. The time variable for Cox regression analysis
was time to death or hospital discharge. Power analysis
was performed extrapolating data from other studies
[18,20]. We assumed that in-hospital mortality would be
10% higher among critically ill patients with 25(OH) D
<20 ng/ml compared to those with 25(OH) D >20 ng/mL.
With an alpha error level of 5% and a sample size of 394
patients with 25(OH) D <20 ng/ml and 261 patients with
25(OH) D >20 ng/mL, the power to detect a difference in
in-hospital mortality was 88%. To determine the optimal
25(OH) D cut point for hospital mortality, we utilized the
Youden Index [29-31]. It was also analyzed for each sea-
son (winter: December, January, February; spring: March,
April, May; summer; June, July, August; fall: September,
October, November). For this analysis, STATA 10.0MP
(StataCorp, College Station, TX, USA) was used.
Definition of vitamin D deficiency
25(OH) D is considered the best available parameter for
the definition vitamin D status [32], because it reflects
vitamin D body stores better than other vitamin D meta-
bolites. To date, consensus on optimal vitamin D levels and
the definition of vitamin D deficiency exists neither in the
general population nor in critically ill patients. Therefore, in
our study, we used the definition recommended by the
Endocrine Society for at-risk populations (25(OH) D ≤
19.9 ng/ml deficiency, 20 to 29.9 ng/ml insufficiency) in
addition to month-specific tertiles in order to reflect sea-
sonal variability [33] and to evaluate if the associations
became stronger in this model.
Vitamin D supplementation
Due to the retrospective nature of the study, detailed
information on vitamin D supplementation was not
available. It is current clinical practice at our institution
to supplement intravenous multivitamin preparations
containing 200 to 220 IU of ergocalciferol or cholecalcif-
erol once a day. As demonstrated in the placebo group
of our pilot study [34], this dose does not influence
25(OH) D levels in serial measurements.
Blood cultures
During hospital stay, blood cultures were taken in 244
patients (37% of the study population). Results were
retrieved from two laboratories: the Institute of Hygiene
and the Section of Infectious Diseases of the Department
of Internal Medicine. All results were thoroughly reviewed
for clinical validity by two specialized physicians otherwise
uninvolved in routine care of the study population. Con-
taminants such as coagulase-negative staphylococcus were
not considered as positive results.Results
Clinical and biochemical characteristics of the popu-
lation are given in Table 1. Primary reasons for ICU
admission were neurologic (157, 30.2%), cardiac surgery
(78, 15.0%) and cardiovascular events (62, 11.9%). Other
causes included respiratory disease (42, 8.1%), trauma
(30, 5.8%), brain surgery (26, 5.0%) and infectious diseases,
including sepsis at admission (23, 4.4%). The mean
25(OH) D level was 19.6 ± 11.3 ng/ml. Vitamin D tertiles
were calculated for each calendar month, based upon
25(OH) D analysis (median overall 25(OH) D levels: 9.7 vs.
16.3 vs. 28.0 ng/ml, P <0.001). The highest level was 79.4
and the lowest 1.3 ng/ml. The majority of all patients was
vitamin D deficient (<20 ng/ml; 60.2%) or insufficient
(≥20 and <30 ng/dl; 26.3%), while normal 25(OH) D levels
(>30 ng/ml) were present in only 13.6% of the population.
There were small, but significant differences between
mean 25(OH) D levels with regard to type of ICU (mixed
surgical 17.6 ± 10.4 ng/ml, medical, 18.6 ± 10.3 ng/ml,
cardiothoracic 19.6 ± 11.9, neurologic 22.9 ± 12.3,
P <0.001). Also, the prevalence of vitamin D deficiency
differed between ICUs (mixed surgical 70%, medical 64%,
cardiothoracic 63%, neurologic 44%, P <0.001).
In survivors, total/ionized calcium levels were sig-
nificantly higher and 25(OH) D/PTH/phosphorus levels
significantly lower compared to nonsurvivors (Table 1).
Some of these parameters also showed significant differ-
ences between vitamin D groups (Table 2).
Season
We observed a clear seasonal variation in 25(OH) D
serum levels, with the highest mean values observed in
August (n = 75, 28.0 ± 13.9 ng/ml). This was signifi-
cantly and almost two-fold higher than the lowest mean
levels found in March (n = 90, 15.4 ± 8.4 ng/ml, P <0.001),
October (n = 16, 15.3 ± 4.9 ng/ml, P <0.001) and November
(n = 23, 14.8 ± 9.0 ng/ml, P <0.001). The prevalence of
vitamin D deficiency was also substantially higher in win-
ter compared to the summer/autumn months. In August,
only 29% were classified as vitamin D deficient, while in
or after winter months, the prevalence reached more
than 80% (March, 84%, October 87% and November 83%)
(Figures 1 and 2). The optimal 25(OH) D cut point for
hospital mortality was 15.2 ng/ml. This was not season
dependent (winter 15.1 ng/ml, spring 15.2 ng/ml, summer
14.9 ng/ml, fall 15.2 ng/ml).
Mortality
All-cause hospital mortality was significantly higher in
patients with vitamin D deficiency compared to patients
with insufficient and sufficient levels, and the results
were even more distinct when hospital mortality rates
were compared between month-specific 25(OH) D tertiles
(Table 2, Figure 3). In adjusted Cox regression analysis,
Table 1 General patient characteristics and comparison between survivors and nonsurvivors
Overall (n = 655) Survivors (n = 520) Nonsurvivors (n = 135)
Gender, n (%)
female 243 (37.1%) 192 (36.9%) 51 (37.8%)
male 412 (62.9%) 328 (63.1%) 84 (62.2%)
Age (years), median (iqr) 65 (22) 64 (23) 69 (20)*
SAPS II, median (iqr) 26 (16) 24 (15) 32 (19)*
Type of ICU, n (%)
medical 238 (36.3%) 178 (34.2%) 60 (44.4%)
neurologic 164 (25.0%) 147 (28.3%) 17 (12.6%)
mixed surgical 150 (22.9%) 112 (21.5%) 38 (28.1%)
cardiothoracic 103 (15.7%) 83 (16.0%) 20 (14.8%)
Length of ICU stay (days), median (iqr) 6.0 (8.31) 5.1 (7.5) 9.1 (10.7)*
Length of hospital stay (days), median (iqr) 14.9 (18.6) 15.9 (19.1) 11.9 (14.1)*
25(OH) D (ng/ml), median (iqr) 17.3 (13.9) 17.9 (14.1) 13.3 (11.4)*
25(OH) D category, n (% of total population)
<20 ng/ml 394 (60.2%) 298 (57.3%) 96 (71.1%)
<12 ng/ml 193 (29.5%) 139 (26.7%) 54 (40.0%)
20-30 ng/ml 172 (26.3%) 148 (28.5%) 24 (17.8%)
>30 ng/ml 89 (13.6%) 74 (14.2%) 15 (11.1%)
30-40 ng/ml 50 (7.6%) 42 (8.1%) 8 (5.9%)
40-50 ng/ml 22 (3.4%) 19 (3.7%) 3 (2.2%)
>50 ng/ml 17 (2.6%) 13 (2.5%) 4 (3.0%)
GFR (ml/min), mean ± sd 83 ± 54 88 ± 54 67 ± 50*
CRP (mg/dl), mean ± sd 102 ± 102 89 ± 93 150 ± 118*
Total calcium (mmol/l), mean ± sd 2.12 ± 0.19 2.14 ± 0.18 2.06 ± 0.20*
Ionized calcium (mmol/l), mean ± sd 1.10 ± 0.11 1.11 ± 0.10 1.06 ± 0.12*
Phosphate (mmol/l), mean ± sd 1.18 ± 0.44 1.15 ± 0.39 1.27 ± 0.58*
PTH (pg/ml), median (iqr) 48 (45) 47 (40) 60 (78)*
*Refers to a statistically significant difference between survivors and nonsurvivors (P <0.05). PTH, phosphate and ionized/total calcium were available in 598, 649
and 202/596 patients, respectively. 25(OH) D, 25-hydroxyvitamin D; CRP, C-reactive protein; GFR, glomerular filtration rate; iqr, interquartile range; PTH, parathyroid
hormone; SAPS II, Simplified Acute Physiology Score II; sd, standard deviation.
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0.93 to 2.86 in vitamin deficiency and 1.01, 95% CI 0.52 to
1.96 in vitamin D insufficiency respectively. For the more
specific 25(OH) D tertiles, however, HRs were 2.05, 95%
CI 1.31 to 3.22 in the low and 1.92, 95% CI 1.21 to 3.06 in
the intermediate tertile respectively. In Cox regression
analysis using 25(OH) D as a continuous variable, the HR
for hospital mortality was 0.979 (95% CI 0.962 to 0.997).
ICU mortality also varied between the three groups,
being only numerically higher in both the deficiency and
insufficiency groups compared to patients with vitamin
D sufficiency. This was also true for the low and inter-
mediate tertile comparisons with the highest tertile
(Table 2, Figure 4). HRs were 1.30, 95% CI 0.61 to 2.75
and 1.61, 95% CI 0.70 to 3.67 for deficiency and insuffi-
ciency, respectively or 1.70, 95% CI 0.98 to 2.96 and 1.6,
95% CI 0.95 to 2.91 for the low and the intermediatetertile, respectively. In Cox regression analysis using
25(OH) D as a continuous variable, the HR for ICU
mortality was 0.997 (95% CI 0.975 to 1.018).
When survival analysis was performed after catego-
rization of vitamin D status into severe deficiency
(<12 ng/ml), deficiency (12 to 20 ng/ml), insufficiency
(20 to 30 ng/ml) and multiple strata of sufficiency (30 to
40 ng/ml, 40 to 50 ng/ml, >50 ng/ml), ICU mortality
was highest in severe deficiency (18.7%) and lowest in
the 30 to 40 ng/ml (6.0%) and the 40 to 50 ng/ml (9.1%)
groups. Patients with 25(OH) D >50 ng/ml had nonsig-
nificantly higher ICU mortality (17.6%). Hospital mortal-
ity was also highest in severe deficiency (28.0%), lowest
between 20 and 50 ng/ml (14.0%, 16.0%, 13.6% res-
pectively) and significantly higher in >50 ng/ml (23.5%;
P = 0.029). In adjusted Cox regression for ICU mortality
using 30 to 40 ng/ml as a reference, HRs (95% CI) were













Gender, male (%) 61.4% 62.2% 70.8% 59.7% 64.8% 64.1%
Age (years), median (iqr) 65 (22) 65 (23) 65 (25) 68 (22) 64 (26) 64 (23)*
SAPS II, median (iqr) 27 (17) 24 (14) 24 (14)* 30 (16) 24 (15) 24 (15)*
Type of ICU, n (%)
medical 38.6% 32.6% 33.7%* 42.1% 36.1% 30.9%*
neurologic 18.3% 33.1% 39.3%* 18.5% 21.9% 34.5%*
mixed surgical 26.6% 18.0% 15.7%* 25.0% 23.7% 20.0%*
cardiothoracic 16.5% 16.3% 11.2%* 14.4% 18.3% 14.5%*
25(OH) D (ng/ml), median (iqr) 12.2 (5.2) 24.4 (4.7) 37.5 (12.9)* 9.7 (3.7) 16.3 (8.4) 28.0 (12.4)*
GFR (ml/min), mean ± sd 85±62 81±38 82±40 83±65 84±55 84±39
CRP (mg/dl), mean ± sd 107±95 82±95 117±132* 110±93 100±98 94±112*
Total calcium (mmol/l), mean ± sd 2.11±0.19 2.15±0.18 2.15±0.15* 2.10±0.19 2.12±0.19 2.16±0.16*
Ionized calcium (mmol/l), mean ± sd 1.09±0.12 1.12±0.10 1.10±0.08 1.09±0.12 1.09±0.11 1.12±0.09
Phosphate (mmol/l), mean ± sd 1.19±0.46 1.16±0.37 1.15±0.45 1.22±0.49 1.16±0.42 1.15±0.41
PTH (pg/ml), median (iqr) 52 (55) 47 (34) 45 (36) 54 (66) 49 (45) 43 (32)*
*Refers to a statistically significant difference between subgroups (P <0.05). 25(OH) D, 25-hydroxyvitamin D; CRP, C-reactive protein; GFR, glomerular filtration rate;
iqr, interquartile range; PTH, parathyroid hormone; SAPS II, Simplified Acute Physiology Score II.
Amrein et al. Critical Care 2014, 18:R47 Page 5 of 12
http://ccforum.com/content/18/2/R47as follows: <12 ng/ml: 2.77 (0.85 to 9.10), 12 to 20 ng/ml:
1.80 (0.54 to 6.08), 20 to 30 ng/ml: 2.86 (0.85 to 9.67), 40
to 50 ng/ml: 2.16 (0.34 to 13.59) and >50 ng/ml: 5.07 (1.00
to 25.77). Results for hospital mortality were similar with
a HR of 2.12 (1.00 to 4.50) for severe deficiency, 1.64 (0.76
to 3.52) for deficiency, 1.17 (0.52 to 2.64) for insufficiency,
1.20 (0.31 to 4.64) for 40 to 50 ng/ml and 1.66 (0.48 to
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Figure 1 Seasonal variation of the prevalence of vitamin D deficiency
was higher in winter compared to the summer/autumn months. In August
winter months, the prevalence reached more than 80% (March, 84%, OctobICU and hospital length of stay
We observed a statistically significant association between
vitamin D deficiency and ICU length of stay (LOS) and a
trend toward longer ICU stay in the low month-specific
tertile. However, there was no association between
hospital LOS and vitamin D status (Table 3). In survivors,
median ICU LOS was 6.1 days in the deficiency group,
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Figure 2 Seasonal cutoff levels and mean 25(OH) D values for month-specific tertiles. The highest mean value was observed in August
(n = 75, 28.0 ± 13.9 ng/ml). This was significantly and almost two-fold higher than the lowest mean level found in March (n = 90, 15.4 ± 8.4 ng/ml,
P <0.001), October (n = 16, 15.3 ± 4.9 ng/ml, P <0.001) and November (n = 23, 14.8 ± 9.0 ng/ml, P <0.001). 25(OH) D, 25-hydroxyvitamin D.
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the low, intermediate and high tertiles (P = 0.281). Median
hospital LOS was 15.8, 16.8 and 15.0 days in the defi-
ciency, insufficiency and sufficiency group (P = 0.982) or
14.8, 16.9 and 15.9 days (P = 0.840) in the tertiles.
There were no significant differences in categorized
causes of death between groups (data not shown).
Vitamin D, sepsis and blood culture positivity
Sepsis was identified as cause of death in 20 of 135
deceased patients (14.8%). Mean 25(OH) D levels were
12.3 ± 5.0 as opposed to 18.2 ± 11.2 ng/ml in patients
who died from other causes (P = 0.022). Not a single
sepsis-related fatality was observed in the highest month-
specific tertile or in vitamin D sufficiency. When adjusted
Cox-regression analysis for lethal sepsis was performed
with 25(OH) D as continuous parameter, HR for 25(OH) D
was 0.903 (95% CI 0.839 to 0.971).
Blood culture results were available for 244 of 655
patients (37.3%). We did not find significant differences
in blood culture positivity rates, neither between month-
specific tertiles nor between the vitamin D sufficient,
insufficient and deficient groups (Table 4).
Discussion
We present data on the association of 25(OH) D levels
and important clinical outcomes in the second largest
cohort of critically ill adults reported. The overall preva-
lence of vitamin D deficiency exceeded 60% and similar
percentages were found in all types of ICUs. Low vitaminD levels were independently associated with all-cause
hospital mortality and remained a significant predictor of
mortality after multivariate adjustment for relevant con-
founders, confirming previous findings of adequately pow-
ered studies in the critically ill [17,18,20,35]. Interestingly,
the survival curves between the groups seemed to separate
only after two weeks, a fact for which our data are unable
to offer an explanation.
In our cohort, all patients who died from sepsis had 25
(OH) D levels <30 ng/ml. This confirms the recent
finding of a small study in which sepsis severity was
significantly associated with a poor vitamin D status and
where all deaths had occurred in patients with 25(OH)
D levels <30 ng/ml [21]. In a mixed population of 196
critically ill patients followed up for 28 days, vitamin D
deficiency was also associated with a trend toward more
infections [36]. Moromizato and colleagues recently
showed that a low 25(OH) D level obtained before
hospital admission is a significant predictor of sepsis in
the critically ill and that these patients have an increased
mortality risk [37].
In our study, the risk for blood culture positivity was
not significantly associated with vitamin D levels in the
subgroup of patients with available blood culture results
(n = 244), a fact that may be attributable to small sample
size, as in the largest ICU cohort reported to date, Braun
et al. found a significantly higher rate of positive blood
cultures (odds ratio 1.64, 95% CI 1.05 to 2.55, P = 0.03)
in patients with a 25(OH) D level of <15 ng/ml (sub-
group: n = 1160).
Figure 3 Unadjusted Kaplan-Meier plot for hospital survival stratified by definition of vitamin D deficiency (a) and month-specific
vitamin D tertiles (b). Using the log-rank test, hospital mortality was significantly different between vitamin D sufficiency, insufficiency and
deficiency (P = 0.034) and vitamin D tertiles (P = 0.004).
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clear association between ICU or hospital LOS and low
vitamin D status in our population. It is of interest,
however, that ICU LOS was longer in nonsurvivors
compared to survivors.
In the context of discussing clinical outcomes in
dependency of 25(OH) D levels, reverse causality needs to
be especially considered in the ICU setting. Here, several
factors such as fluid loading, acute inflammatory statesand lower vitamin D binding protein may affect 25(OH) D
levels [39-41]. We are unable to ultimately confirm or
reject such observations because details on fluid intakes
or vitamin D binding protein levels are unavailable for our
cohort. However, in our Cox analysis we included a simul-
taneous CRP level as a measure of the intensity of the sys-
temic inflammatory response. This is important because a
low vitamin D level during hospitalization might only
reflect greater degree of inflammation, which would likely
Figure 4 Unadjusted Kaplan-Meier plot for ICU survival stratified by definition of vitamin D deficiency (a) and month-specific vitamin
D tertiles (b). Using the log-rank test, ICU mortality was not significantly different between groups (P = 0.893 for vitamin D sufficiency/insufficiency/
deficiency classification and 0.164 for tertiles).
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remained significant with inclusion of CRP in the model
suggests that vitamin D levels are truly per se associated
with adverse outcomes.
There is a large body of data supporting the concept
that vitamin D plays a decisive role in both the innate
and the adaptive immune system [24,25,42]. Vitamin D
also upregulates the production of important antimicro-
bial peptides such as β-defensins and cathelicidins thatare expressed in barrier tissues like airway, bladder and
gastrointestinal epithelium, which are active against
many bacteria and fungi, thus protecting the individual
from hospital-acquired infection at these important po-
tential entry sites [43]. In critically ill patients, a sig-
nificant positive correlation between cathelicidin and
25(OH) D serum levels has been reported and cathelici-
din levels were lower compared to healthy controls [10].
In a prospective cohort of 112 hospitalized patients with
Table 3 Descriptive comparison of ICU, hospital and sepsis mortality rates by χ2-test and median ICU and hospital
length of stay (LOS) analyzed by Kruskal-Wallis test
n ICU mortality Hospital mortality Sepsis mortality ICU LOS Hospital LOS
n (%) P n (%) P n (%) P Median (iqr) P Median (iqr) P
Overall 655 88 (13.4%) 135 (20.6%) 20 (3.1%) 6.0 (5.1) 14.9 (12.4)
Vitamin D classification (ng/ml)
deficiency, <20 394 58 (14.7%) 0.344 96 (24.4%) 0.012 19 (4.8%) 0.005 6.9 (9.8) 0.004 15.1 (19.1) 0.743
insufficiency, 20-30 172 22 (12.8%) 24 (14.0%) 2 (0.6%) 4.9 (7.7) 15.0 (18.7)
sufficiency, >30 89 8 (9.0%) 15 (16.9%) 0 (0.0%) 5.2 (6.5) 13.5 (16.8)
Vitamin D month specific tertiles
low 216 35 (16.2%) 0.064 58 (26.9%) 0.002 11 (5.1%) 0.005 6.7 (8.5) 0.097 14.2 (19.6) 0.908
intermediate 219 33 (15.1%) 48 (21.9%) 9 (4.1%) 6.7 (9.0) 15.4 (17.4)
high 220 20 (9.1%) 29 (13.2%) 0 (0.0%) 5.0 (7.7) 14.8 (18.5)
P values refer to differences between subgroups. iqr, interquartile range.
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nor β-defensin-2 levels correlated with 25(OH) D status,
but there was a trend toward increased mortality with
lower cathelicidin levels [44]. Furthermore, severe vita-
min D deficiency (<12 ng/ml) was associated with an
OR of 12.7 (95% CI, 2.2 to 73.3) for the 30-day mortality
compared to patients with 25(OH) D levels above 20 ng/ml
[44]. In an elegant Swedish study using bladder biopsies
from healthy postmenopausal women, 2,000 IU of chole-
calciferol daily significantly increased cathelicidin produc-
tion after infection with Escherichia coli associated with a
direct antibacterial effect [45]. In summary, our data
are in line with hypotheses suggesting that vitamin D
status is an important contributor to sepsis incidence
and outcome [11,46-48].
Another relevant finding of our study is that vitamin
D status was surprisingly dependent on season with a
maximum difference of a factor of two between the low-
est levels in or after winter and the highest levels inTable 4 Descriptive subgroup analysis (n = 244): blood
culture positivity rates analyzed with χ2-test
n Blood culture positivity
n (%) P
Overall 244 55 (22.5%)
Vitamin D classification (ng/ml)
deficiency, <20 160 34 (22.2%) 0.641
insufficiency, 20-30 51 14 (29.2%)
sufficiency, >30 33 7 (21.2%)
Vitamin D month-specific tertiles
low 87 20 (23.1%) 0.361
intermediate 82 22 (28.2%)
high 75 13 (17.1%)
There was no significant association between 25(OH) D and CRP (R = −0.009,
P = 0.81), leukocyte count (R = −0.011, P = 0.79) or procalcitonin levels (R =
0.022, P = 0.679, n = 372).August. In other populations, vitamin D status is
dependent on season as well [49-52], however, it may be
expected that critically ill patients are much less affected
by this change because they are often severely restricted in
their mobility even before acute illness so that the cutane-
ously produced amount of vitamin D may be very limited.
Our results clearly demonstrate that critically ill patients
are not exempt from this general rule with even the mag-
nitude of variation being similar to healthy individuals
[51]. Interestingly, the strong seasonal variation closely
resembles the described seasonal variation of respiratory
tract infections, invasive pneumococcal disease and sepsis
[53,54]. Of note, the optimal 25(OH) D cut point for hos-
pital mortality was not season dependent at 15 ng/ml.
In a large cohort of cardiac surgical patients (n = 4,418),
Zittermann and colleagues recently demonstrated a sig-
nificantly increased risk of major cardiac and cerebrovas-
cular events (defined as in-hospital death, myocardial
infarction, low output syndrome and stroke) in patients
with low (<20 ng/ml), but also high-normal vitamin D
status (>40 ng/ml) [55]. Similar results were observed for
mechanical ventilation, ICU and hospital stay. The rea-
sons for this finding are unclear to date. At 25(OH) D
levels >50 ng/ml, we also observed a higher risk for
hospital mortality in our population of mixed critically ill
patients. Obviously, this analysis was limited by its small
sample size (n = 17, or 2.6% of all patients), but requires
special future consideration, as levels in this range are
certainly not considered toxic and do not cause hypercal-
cemia [56]. Such a correlation might also be attributable
to vitamin D supplementation in previously deficient
patients who are more likely to have a compromised
health status.
Limitations
The most important limitation of this study is its
retrospective observational single-center design, which
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bias may be present. Although this is one of the largest
published cohorts on this topic, it is still of a relatively
small sample size for the detection of less pronounced
effects so we had insufficient statistical power to detect
weaker associations. Unfortunately, for logistic reasons it
was impossible to collect data on patients who did not
have 25(OH) D measured. Based on the number of
patients who stayed in the ICUs in the year before data
collection and the collection time frame of 20 months, we
have data available for approximately 23% of patients
staying >48 hours in ICU and, while 25(OH) D levels were
available only in a minority, it was nevertheless a sub-
stantially larger fraction compared to other retrospective
studies on this topic that included 2 to 5% of the treated
population.
Due to data limitations, we are also unable to provide
details on 1,25(OH)2D levels, premorbid health status
and acute or chronic liver failure, the use of vitamin D
supplements, the type of infection and detailed data on
ICU morbidity such as organ dysfunction or the dur-
ation or intensity of mechanical respiratory or inotropic
support. Often critically ill patients have lower albumin,
liver dysfunction and therefore lower vitamin D binding
protein, which is associated with lower 25(OH) D levels
that are still considered to be normal when free levels
are normal.
The accuracy of 25(OH) D assays may be influenced
by a variety of factors [57,58] and in critical illness this is
further complicated by a number of specific patient-
related factors [39,58]. The used assays are not as accur-
ate as the expensive gold standard liquid chromatog-
raphy/tandem mass spectrometry [41], but we used fresh
blood samples for 25(OH) D analysis, which was per-
formed on a daily basis in our institution and the used
assays are currently widely available tests for routine
use. Finally, our study was performed in a Caucasian
population in a European academic tertiary care center
and may, therefore, be limited in its generalizability.
Conclusions
Our data demonstrate that low vitamin D levels are highly
prevalent in critical illness and linked to higher all-cause
and sepsis mortality independent of other important con-
tributors. These findings are important because vitamin D
deficiency is a condition that may be easily treated. Com-
pared to other adjunctive interventions used in critical
care in general and in sepsis in particular, vitamin D
supplementation is a simple, inexpensive and safe therapy.
In a pilot study, we have previously shown that a high
dose of oral cholecalciferol (540,000 IU loading dose) is
able to correct vitamin D deficiency rapidly in most
patients [34]. However, adequately powered prospect-
ive RCTs are urgently required to evaluate the effectof vitamin D substitution on mortality, sepsis rates
and other clinically relevant outcomes in critically ill
patients.
Key messages
 25(OH) D deficiency is common across different
ICUs.
 Vitamin D status exhibits a strong seasonal
variation.
 25(OH) D status is significantly associated with
all-cause hospital mortality. The lowest mortality
was apparent between 20 and 40 ng/ml.
 Lethal sepsis occurred only in patients with
25(OH) D levels <30 ng/ml.
 The optimal 25(OH) D cut point for hospital
mortality was 15 ng/ml.
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